Invicta Diagnostic's Subsidiary Incorporates New Entity for Diagnostics and Pathology Services
Invicta Diagnostic Limited has expanded its operational scope in the healthcare sector with the incorporation of Porteus Pathogenius LLP. This new entity has become a Step-Down Subsidiary following the execution of its initial LLP agreement on June 12, 2026.Porteus Medical LLP, a subsidiary of Invicta Diagnostic Limited, established the limited liability partnership (LLP). The move signifies the group's commitment to expanding business operations within the healthcare and diagnostics industry.
The newly incorporated Porteus Pathogenius LLP is intended to undertake various services related to diagnostics, pathology, and laboratory services. It was established with an initial total capital contribution of Rs. 1,00,000/-.
To secure a majority stake in the new entity, Porteus Medical LLP provided an initial investment of Rs. 51,000/- towards its partnership interest. This investment secured a 51% partnership interest and control in Porteus Pathogenius LLP, making it a Step-Down Subsidiary of Invicta Diagnostic Limited.
While the LLP has been incorporated and the agreement executed, as of yet turnover is reported as Nil. The entity was established under the Limited Liability Partnership Act, 2008, and is preparing to commence business operations.
Key details regarding the establishment of Porteus Pathogenius LLP are summarized below:
| Particulars | Details |
|---|---|
| Entity Name | Porteus Pathogenius LLP |
| Type of Establishment | Limited Liability Partnership (LLP) |
| Industry Focus | Healthcare / Diagnostics / Pathology Services |
| Initial Total Capital Contribution | Rs. 1,00,000/- |
| Investment by Porteus Medical LLP | Rs. 51,000/- |
| Stake Acquired | 51% partnership interest/control |
The transaction is not defined as a related party transaction, given that Porteus Pathogenius LLP was incorporated as a new entity by Porteus Medical LLP, which is a subsidiary of Invicta Diagnostic Limited. The move allows the group to concentrate efforts on expanding its presence in diagnostics and pathology services.
INVICTA Stock Price Movement
Today, shares of Invicta Diagnostic Limited shed 1.80%, finishing the trading day at ₹59.90. The stock saw a traded volume of 17,600 shares as it settled in the post-market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.